Faculty profile
Lucy Ma
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer: A Single Institution Retrospective Cohort Review.
Practical radiation oncology · 2026
Implementation of medication reconciliation in outpatient cancer care.
BMJ open quality · 2023
Latest funding
- $929,475
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
CIHR · 2023 · Co-investigator
- $2,995,962
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
CIHR · 2022 · Co-investigator
- $748,990
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
CIHR · 2022 · Co-investigator
2 publications.
External Beam Radiotherapy in the Management of Differentiated Thyroid Cancer: A Single Institution Retrospective Cohort Review.
Bartolucci D, Agarwal M, Ye XY, Adeoya D, Tsang RWC, Mete O, Madani A, Ma L, Barron C, Brierley J, Lukovic J, Mesci A
Implementation of medication reconciliation in outpatient cancer care.
Powis M, Dara C, Macedo A, Hack S, Ma L, Mak E, Morley L, Kukreti V, Dave H, Kirkby R, Krzyzanowska MK
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
Principal investigators: Zimmermann, Camilla
Keywords: Clinical Oncology; Early Palliative Care; Nurse Triage; Quality Of Life; Randomised Controlled Trial; Satisfaction With Care; Supportive Care; Symptom Control; Symptom Screening
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
Principal investigators: Elimova, Elena; Goodwin, Rachel A; Lim, Howard; O'Callaghan, Christopher J; Tu, Dongsheng
Keywords: Clinical Trial; Gastroesophageal Cancer; Her 2 Positive
A randomized phase II study of ramucirumab and paclitaxel +/- zanidatamab in HER2 overexpressing advanced gastroesophageal adenocarcinoma
Principal investigators: Elimova, Elena; Goodwin, Rachel A; Lim, Howard; O'Callaghan, Christopher J; Tu, Dongsheng
Keywords: Clinical Trial; Gastroesophageal Cancer; Her 2 Positive
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
- Monika Krzyzanowska and Melanie Powis: 88 shared papers
- Jelena Lukovic and Aruz Mesci: 10 shared papers
- Monika Krzyzanowska and Jelena Lukovic: 7 shared papers
- Monika Krzyzanowska and James Brierley: 6 shared papers
- Jelena Lukovic and Ozgur Mete: 4 shared papers
- Jelena Lukovic and James Brierley: 4 shared papers
- Ozgur Mete and Aruz Mesci: 4 shared papers
- Monika Krzyzanowska and Ozgur Mete: 3 shared papers
- Ozgur Mete and James Brierley: 3 shared papers
- James Brierley and Aruz Mesci: 2 shared papers
- Monika Krzyzanowska and Lucy Ma: 1 shared paper
- Jelena Lukovic and Carly Barron: 1 shared paper
- Jelena Lukovic and Lucy Ma: 1 shared paper
- Jelena Lukovic and Amin Madani: 1 shared paper
- Melanie Powis and Lucy Ma: 1 shared paper
- Ozgur Mete and Carly Barron: 1 shared paper
- Ozgur Mete and Lucy Ma: 1 shared paper
- Ozgur Mete and Amin Madani: 1 shared paper
- Carly Barron and James Brierley: 1 shared paper
- Carly Barron and Lucy Ma: 1 shared paper
- Carly Barron and Amin Madani: 1 shared paper
- James Brierley and Lucy Ma: 1 shared paper
- Aruz Mesci and Lucy Ma: 1 shared paper
- Lucy Ma and Amin Madani: 1 shared paper
- Department of Medicine
- Department of Radiation Oncology
- Department of Surgery
- Institute of Health Policy, Management, and Evaluation
- Department of Laboratory Medicine & Pathobiology
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Amin Madani
Department of Surgery
1 shared papers, latest 2026
Monika Krzyzanowska
Department of Medicine
1 shared papers, latest 2023
Jelena Lukovic
Department of Radiation Oncology
1 shared papers, latest 2026
Melanie Powis
Institute of Health Policy, Management, and Evaluation
1 shared papers, latest 2023
Ozgur Mete
Department of Laboratory Medicine & Pathobiology
1 shared papers, latest 2026
Carly Barron
Department of Medicine
1 shared papers, latest 2026
James Brierley
Department of Radiation Oncology
1 shared papers, latest 2026
Aruz Mesci
Department of Radiation Oncology
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.